<?xml version="1.0" encoding="UTF-8"?>
<p>Due to the sporadic nature of these infections, the immunologically naive population affected, and the persistent circulation of evolutionarily diverse IAVs in the swine host, the Centers for Disease Control and Prevention and other World Health Organization (WHO) Collaborating Centers for Influenza and Essential Regulatory Laboratories have developed prepandemic CVVs that target specific swine influenza virus subtypes and HA gene lineages that have caused variant virus infections (
 <xref rid="B6" ref-type="bibr">6</xref>). To date, 11 CVVs representing antigenically diverse groups of swine influenza viruses have been proposed or already developed for prepandemic preparedness purposes (
 <ext-link ext-link-type="uri" xlink:href="https://www.who.int/influenza/vaccines/virus/en/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/influenza/vaccines/virus/en/</ext-link>).
</p>
